CorVel Corporation — Form 10-Q Summary
Period: Quarter and six months ended September 30, 2012; comparative periods ended September 30, 2011. The request metadata says “2011 Q2,” but the filing itself reports the second quarter of fiscal 2013, not 2011.
Business context
CorVel provides medical cost-containment and managed-care services, primarily for workers’ compensation and auto claims. Its two service categories are Patient Management and Network Solutions; the company reports one operating segment.
Financial results
| Metric | Three months ended Sep. 30, 2012 | Change vs. 2011 | Six months ended Sep. 30, 2012 | Change vs. 2011 |
|---|---|---|---|---|
| Revenue | $105.5 million | +0.9% | $210.1 million | +1.5% |
| Gross profit | $22.8 million | -10.8% | $46.0 million | -10.0% |
| Gross margin | 21.7% | 24.5% prior year | 21.9% | 24.7% prior year |
| Income before tax | $10.9 million | -16.6% | $21.9 million | -16.8% |
| Net income | $6.6 million | -15.9% | $13.2 million | -17.7% |
| Diluted EPS | $0.58 | $0.68 prior year | $1.16 | $1.37 prior year |
Quarterly G&A expense decreased 4.9% to $12.0 million; six-month G&A fell 2.9% to $24.2 million. Diluted weighted-average shares declined 2.5% for the quarter and 2.8% for the six months, principally due to repurchases. Six-month operating cash flow was $23.9 million, compared with $15.9 million a year earlier. Investing used $6.3 million, mainly for property and equipment, and financing used $4.1 million, including $6.9 million for treasury-stock purchases.
Financial position and liquidity
At September 30, 2012, cash and cash equivalents were $20.0 million, up from $6.6 million at March 31, 2012. Working capital was $48.0 million, compared with $36.5 million at fiscal year-end. Total assets were $179.9 million and stockholders’ equity was $119.9 million. The company reported no debt outstanding. Its renewed revolving credit facility provides up to $10 million and expires in September 2013; $8 million of letters of credit were issued separately and do not reduce borrowing availability. Contractual obligations included $44.9 million of operating lease payments, including $12.4 million due within one year.
Changes, outlook, risks and unusual items
- Patient Management revenue increased 10% in the quarter, supported by new TPA customers; Network Solutions declined because of lower volume and the loss of several smaller customers. For the six months, Patient Management revenue rose 9% to about $107 million, while Network Solutions fell 6% to about $103 million.
- Cost of revenue rose faster than sales, reflecting added direct labor for TPA business, higher prescription-processing costs, and a shift toward lower-margin services. Management attributed lower G&A to cost controls and selective staff reductions amid slower growth.
- Management said cash, operating cash flow and expected option-exercise proceeds should fund obligations, share repurchases and business initiatives for at least 12 months. No quantified revenue or earnings guidance was provided; management cautioned that interim results are not necessarily indicative of full-year results.
- The $9 million Louisiana class-action settlement received final, non-appealable approval in January 2012; related dismissals were still being completed. The Illinois class settlement’s final payments were sent in July 2012, with court accounting expected in November. Management said other ordinary-course matters were not expected to result in material payments.
- Key disclosed risks include competition and customer loss, declining workers’ compensation claims or outsourced work, wage and benefit costs, changing healthcare regulation, litigation and insurance costs, and information-system disruption or security breaches. Management reported no goodwill or long-lived-asset impairment at September 30, 2012.
- After quarter-end, CorVel repurchased 30,628 shares for $1.355 million, averaging $44.24 per share. The filing also reported effective disclosure controls and no material change in internal control during the quarter.
Most important facts for investors to verify
- Confirm the reporting period: the filing covers the quarter ended September 30, 2012, despite the request’s “2011 Q2” label.
- Track whether Patient Management growth can offset Network Solutions declines, and whether labor, pharmacy costs and service mix continue to pressure gross margins.
- Review operating cash conversion, capital spending, share repurchases, and the company’s ability to preserve liquidity while meeting $44.9 million of lease commitments.
- Check the status of remaining court dismissals and routine litigation, as well as the $991,000 uncertain-tax-position balance and self-insurance estimates.
- Monitor use and availability of the renewed credit facility, including covenant compliance and the September 2013 expiration.